Annual Operating Profit
-$172.87 M
-$57.71 M-50.12%
31 December 2023
Summary:
Akero Therapeutics annual operaing income is currently -$172.87 million, with the most recent change of -$57.71 million (-50.12%) on 31 December 2023. During the last 3 years, it has fallen by -$92.72 million (-115.67%). AKRO annual operating profit is now -1154.68% below its all-time high of -$13.78 million, reached on 31 December 2018.AKRO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$81.70 M
-$15.96 M-24.28%
30 September 2024
Summary:
Akero Therapeutics quarterly operating income is currently -$81.70 million, with the most recent change of -$15.96 million (-24.28%) on 30 September 2024. Over the past year, it has dropped by -$35.09 million (-75.27%). AKRO quarterly operating profit is now -19306.89% below its all-time high of -$421.00 thousand, reached on 31 March 2018.AKRO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$269.27 M
-$35.09 M-14.98%
30 September 2024
Summary:
Akero Therapeutics TTM operating income is currently -$269.27 million, with the most recent change of -$35.09 million (-14.98%) on 30 September 2024. Over the past year, it has dropped by -$132.85 million (-97.39%). AKRO TTM operating profit is now -63859.86% below its all-time high of -$421.00 thousand, reached on 31 March 2018.AKRO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -50.1% | -75.3% | -97.4% |
| 3 y3 years | -115.7% | -235.5% | -174.1% |
| 5 y5 years | -1154.7% | -401.0% | -731.1% |
AKRO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -115.7% | at low | -235.5% | at low | -174.1% | at low |
| 5 y | 5 years | -1154.7% | at low | -560.0% | at low | -731.1% | at low |
| alltime | all time | -1154.7% | at low | <-9999.0% | at low | <-9999.0% | at low |
Akero Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$81.70 M(+24.3%) | -$269.27 M(+15.0%) |
| June 2024 | - | -$65.74 M(+9.7%) | -$234.18 M(+14.8%) |
| Mar 2024 | - | -$59.95 M(-3.1%) | -$204.07 M(+18.0%) |
| Dec 2023 | -$172.87 M(+50.1%) | -$61.87 M(+32.7%) | -$172.87 M(+26.7%) |
| Sept 2023 | - | -$46.62 M(+30.8%) | -$136.42 M(+8.4%) |
| June 2023 | - | -$35.63 M(+23.9%) | -$125.89 M(+6.8%) |
| Mar 2023 | - | -$28.75 M(+13.1%) | -$117.86 M(+2.3%) |
| Dec 2022 | -$115.16 M(+14.1%) | -$25.42 M(-29.6%) | -$115.16 M(-5.7%) |
| Sept 2022 | - | -$36.09 M(+30.8%) | -$122.17 M(+10.6%) |
| June 2022 | - | -$27.59 M(+5.9%) | -$110.44 M(-1.2%) |
| Mar 2022 | - | -$26.05 M(-19.7%) | -$111.81 M(+10.8%) |
| Dec 2021 | -$100.89 M | -$32.44 M(+33.2%) | -$100.89 M(+2.7%) |
| Sept 2021 | - | -$24.35 M(-15.9%) | -$98.23 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$28.97 M(+91.5%) | -$95.42 M(+15.1%) |
| Mar 2021 | - | -$15.13 M(-49.2%) | -$82.90 M(+3.4%) |
| Dec 2020 | -$80.15 M(+75.6%) | -$29.78 M(+38.3%) | -$80.15 M(+20.4%) |
| Sept 2020 | - | -$21.54 M(+30.9%) | -$66.59 M(+8.5%) |
| June 2020 | - | -$16.45 M(+32.9%) | -$61.36 M(+16.8%) |
| Mar 2020 | - | -$12.38 M(-23.7%) | -$52.52 M(+15.0%) |
| Dec 2019 | -$45.65 M(+231.3%) | -$16.22 M(-0.5%) | -$45.65 M(+40.9%) |
| Sept 2019 | - | -$16.31 M(+114.3%) | -$32.40 M(+81.8%) |
| June 2019 | - | -$7.61 M(+38.0%) | -$17.82 M(-5.6%) |
| Mar 2019 | - | -$5.51 M(+85.7%) | -$18.87 M(+37.0%) |
| Dec 2018 | -$13.78 M | -$2.97 M(+71.9%) | -$13.78 M(+27.5%) |
| Sept 2018 | - | -$1.73 M(-80.1%) | -$10.81 M(+19.0%) |
| June 2018 | - | -$8.66 M(+1957.5%) | -$9.08 M(+2057.5%) |
| Mar 2018 | - | -$421.00 K | -$421.00 K |
FAQ
- What is Akero Therapeutics annual operaing income?
- What is the all time high annual operating profit for Akero Therapeutics?
- What is Akero Therapeutics annual operating profit year-on-year change?
- What is Akero Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Akero Therapeutics?
- What is Akero Therapeutics quarterly operating profit year-on-year change?
- What is Akero Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Akero Therapeutics?
- What is Akero Therapeutics TTM operating profit year-on-year change?
What is Akero Therapeutics annual operaing income?
The current annual operating profit of AKRO is -$172.87 M
What is the all time high annual operating profit for Akero Therapeutics?
Akero Therapeutics all-time high annual operaing income is -$13.78 M
What is Akero Therapeutics annual operating profit year-on-year change?
Over the past year, AKRO annual operaing income has changed by -$57.71 M (-50.12%)
What is Akero Therapeutics quarterly operating income?
The current quarterly operating profit of AKRO is -$81.70 M
What is the all time high quarterly operating profit for Akero Therapeutics?
Akero Therapeutics all-time high quarterly operating income is -$421.00 K
What is Akero Therapeutics quarterly operating profit year-on-year change?
Over the past year, AKRO quarterly operating income has changed by -$35.09 M (-75.27%)
What is Akero Therapeutics TTM operating income?
The current TTM operating profit of AKRO is -$269.27 M
What is the all time high TTM operating profit for Akero Therapeutics?
Akero Therapeutics all-time high TTM operating income is -$421.00 K
What is Akero Therapeutics TTM operating profit year-on-year change?
Over the past year, AKRO TTM operating income has changed by -$132.85 M (-97.39%)